Managing medications among individuals with mild cognitive impairment and dementia: Patient-caregiver perspectives.
caregiver
dementia
dyads
medication
mild cognitive impairment
Journal
Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062
Informations de publication
Date de publication:
15 Jul 2024
15 Jul 2024
Historique:
revised:
05
06
2024
received:
03
04
2024
accepted:
13
06
2024
medline:
15
7
2024
pubmed:
15
7
2024
entrez:
15
7
2024
Statut:
aheadofprint
Résumé
With changing cognitive abilities, individuals with mild cognitive impairment (MCI) and dementia face challenges in successfully managing multidrug regimens. We sought to understand how individuals with MCI or dementia and their family caregivers manage multidrug regimens and better understand patient-to-caregiver transitions in medication management responsibilities. We conducted qualitative interviews among patient-caregiver dyads. Eligibility included: patients with a diagnosis of MCI, mild or moderate dementia, managing ≥3 chronic conditions, ≥5 prescription medications, who also had a family caregiver ≥18 years old. Semi-structured interview guides, informed by the Medication Self-Management model, ascertained roles and responsibilities for medication management and patient-to-caregiver transitions in medication responsibilities. We interviewed 32 patient-caregiver dyads. Older adults and caregivers favored older adult autonomy in medication management, and individuals with MCI and mild dementia largely managed their medications independently using multiple strategies (e.g., establishing daily routines, using pillboxes). Among individuals with moderate dementia, caregivers assumed all medication-related responsibilities except when living separately. In those scenarios, caregivers set up organizers and made reminder calls, but did not observe family members taking medications. Patient-to-caregiver transitions in medication responsibilities frequently occurred after caregivers observed older adults making errors with medications. As caregivers sought to assume greater responsibilities with family members' medicines, they faced multiple barriers. Most barriers were dyadic; they affected both the older adult and the caregiver and/or the relationship. Some barriers were specific to caregivers; these included caregivers' competing responsibilities or inaccurate perceptions of dementia, while other barriers were related to the healthcare system. To ease medication management transitions, balance must be sought between preservation of older adult autonomy and early family caregiver involvement. Clinicians should work to initiate conversations with family caregivers and individuals living with MCI or dementia about transitioning medication responsibilities as memory loss progresses, simplify regimens, and deprescribe, as appropriate.
Sections du résumé
BACKGROUND
BACKGROUND
With changing cognitive abilities, individuals with mild cognitive impairment (MCI) and dementia face challenges in successfully managing multidrug regimens. We sought to understand how individuals with MCI or dementia and their family caregivers manage multidrug regimens and better understand patient-to-caregiver transitions in medication management responsibilities.
METHODS
METHODS
We conducted qualitative interviews among patient-caregiver dyads. Eligibility included: patients with a diagnosis of MCI, mild or moderate dementia, managing ≥3 chronic conditions, ≥5 prescription medications, who also had a family caregiver ≥18 years old. Semi-structured interview guides, informed by the Medication Self-Management model, ascertained roles and responsibilities for medication management and patient-to-caregiver transitions in medication responsibilities.
RESULTS
RESULTS
We interviewed 32 patient-caregiver dyads. Older adults and caregivers favored older adult autonomy in medication management, and individuals with MCI and mild dementia largely managed their medications independently using multiple strategies (e.g., establishing daily routines, using pillboxes). Among individuals with moderate dementia, caregivers assumed all medication-related responsibilities except when living separately. In those scenarios, caregivers set up organizers and made reminder calls, but did not observe family members taking medications. Patient-to-caregiver transitions in medication responsibilities frequently occurred after caregivers observed older adults making errors with medications. As caregivers sought to assume greater responsibilities with family members' medicines, they faced multiple barriers. Most barriers were dyadic; they affected both the older adult and the caregiver and/or the relationship. Some barriers were specific to caregivers; these included caregivers' competing responsibilities or inaccurate perceptions of dementia, while other barriers were related to the healthcare system.
CONCLUSIONS
CONCLUSIONS
To ease medication management transitions, balance must be sought between preservation of older adult autonomy and early family caregiver involvement. Clinicians should work to initiate conversations with family caregivers and individuals living with MCI or dementia about transitioning medication responsibilities as memory loss progresses, simplify regimens, and deprescribe, as appropriate.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCATS NIH HHS
ID : UL1TR001422
Pays : United States
Organisme : NIA NIH HHS
ID : K01AG070107
Pays : United States
Organisme : NIA NIH HHS
ID : P30AG013854
Pays : United States
Organisme : NIA NIH HHS
ID : P30AG059988
Pays : United States
Informations de copyright
© 2024 The Author(s). Journal of the American Geriatrics Society published by Wiley Periodicals LLC on behalf of The American Geriatrics Society.
Références
Alzheimer's Association. Alzheimer's Disease Facts and Figures. 2023.
Manly JJ, Jones RN, Langa KM, et al. Estimating the prevalence of dementia and mild cognitive impairment in the US: the 2016 health and retirement study harmonized cognitive assessment protocol project. JAMA Neurol. 2022;79(12):1242‐1249.
Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Focus. 2013;11(1):96‐106.
Schubert CC, Boustani M, Callahan CM, et al. Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc. 2006;54(1):104‐109.
Doraiswamy PM, Leon J, Cummings JL, Marin D, Neumann PJ. Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2002;57(3):M173‐M177.
Bauer K, Schwarzkopf L, Graessel E, Holle R. A claims data‐based comparison of comorbidity in individuals with and without dementia. BMC Geriatr. 2014;14:10.
Growdon ME, Gan S, Yaffe K, Steinman MA. Polypharmacy among older adults with dementia compared with those without dementia in the United States. J Am Geriatr Soc. 2021;69(9):2464‐2475.
Bailey SC, Oramasionwu CU, Wolf MS. Rethinking adherence: a health literacy‐informed model of medication self‐management. J Health Commun. 2013;18(Suppl 1):20‐30.
Wolf MS, Curtis LM, Waite K, et al. Helping patients simplify and safely use complex prescription regimens. Arch Intern Med. 2011;171(4):300‐305.
Davis TC, Wolf MS, Bass PF 3rd, et al. Literacy and misunderstanding prescription drug labels. Ann Intern Med. 2006;145(12):887‐894.
Wolf MS, Davis TC, Tilson HH, Bass PF 3rd, Parker RM. Misunderstanding of prescription drug warning labels among patients with low literacy. Am J Health‐Syst Pharm. 2006;63(11):1048‐1055.
Farber HJ, Capra AM, Finkelstein JA, et al. Misunderstanding of asthma controller medications: association with nonadherence. J Asthma. 2003;40(1):17‐25.
Lindquist LA, Lindquist LM, Zickuhr L, Friesema E, Wolf MS. Unnecessary complexity of home medication regimens among seniors. Patient Educ Couns. 2014;96(1):93‐97.
Bailey SC, Opsasnick LA, Curtis LM, et al. Longitudinal investigation of older Adults' ability to self‐manage complex drug regimens. J Am Ger Soc. 2020;68(3):569‐575.
O'Conor R, Muellers K, Arvanitis M, et al. Effects of health literacy and cognitive abilities on COPD self‐management behaviors: a prospective cohort study. Respir Med. 2019;160:105630.
O'Conor R, Wolf MS, Smith SG, et al. Health literacy, cognitive function, proper use, and adherence to inhaled asthma controller medications among older adults with asthma. Chest. 2015;147(5):1307‐1315.
Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11‐23. doi:10.1016/j.amjopharm.2011.02.004
Gellad WF, Haas JS, Safran DG. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med. 2007;22(11):1572‐1578.
Marcum ZA, Gellad WF. Medication adherence to multidrug regimens. Clin Geriatr Med. 2012;28(2):287‐300.
Hughes CM. Medication non‐adherence in the elderly: how big is the problem? Drugs Aging. 2004;21(12):793‐811.
El‐Saifi N, Moyle W, Jones C, Tuffaha H. Medication adherence in older patients with dementia: a systematic literature review. J Pharm Pract. 2018;31(3):322‐334.
Smith D, Lovell J, Weller C, et al. A systematic review of medication non‐adherence in persons with dementia or cognitive impairment. PLoS One. 2017;12(2):e0170651.
Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412‐2414.
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566‐572. (In eng).
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata‐driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377‐381.
Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi‐disciplinary health research. BMC Med Res Methodol. 2013;13(1):117.
O'Conor R, Eifler M, Russell AM, et al. Caregiver involvement in managing medications among older adults with multiple chronic conditions. J Am Geriatr Soc. 2021;69(10):2916‐2922.
Pohontsch NJ, Loffler A, Luck T, et al. Informal caregivers' perspectives on health of and (potentially inappropriate) medication for (relatively) independent oldest‐old people ‐ a qualitative interview study. BMC Geriatr. 2018;18(1):169.
Travis SS, McAuley WJ, Dmochowski J, Bernard MA, Kao HF, Greene R. Factors associated with medication hassles experienced by family caregivers of older adults. Patient Educ Couns. 2007;66(1):51‐57.
Choi H, Langa KM, Norton EC, Cho TC, Connell CM. Changes in care use and financial status associated with dementia in older adults. JAMA Intern Med. 2023;183(12):1315‐1323.
Anderson TS, Ayanian JZ, Curto VE, et al. Changes in the use of long‐term medications following incident dementia diagnosis. JAMA Intern Med. 2023;183(10):1098‐1108.
While C, Duane F, Beanland C, Koch S. Medication management: the perspectives of people with dementia and family carers. Dementia. 2013;12(6):734‐750.
Lam A, Ploeg J, Carroll SL, Duggleby W, McAiney C, Julian P. Transition experiences of caregivers of older adults with dementia and multiple chronic conditions: an interpretive description study. SAGE Open Nurs. 2020;6:2377960820934290.
Lin PJ, Fillit HM, Cohen JT, Neumann PJ. Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disorders. Alzheimers Dement. 2013;9(1):30‐38.
Griffin JM, Riffin C, Havyer RD, et al. Integrating family caregivers of people with Alzheimer's disease and dementias into clinical appointments: identifying potential best practices. J Appl Gerontol. 2020;39(11):1184‐1194.
Pillemer K, Czaja SJ, Reid MC. Caring for chronically ill older adults: a view over the last 75 years. J Gerontol B Psychol Sci Soc Sci. 2020;75(10):2165‐2169.
Hirschman KB, Hodgson NA. Evidence‐based interventions for transitions in Care for Individuals Living with Dementia. Gerontologist. 2018;58(suppl_1):S129‐S140.
Davis MA, Lee KA, Harris M, et al. Time to dementia diagnosis by race: a retrospective cohort study. J Am Geriatr Soc. 2022;70(11):3250‐3259.
Tsoy E, Kiekhofer RE, Guterman EL, et al. Assessment of racial/ethnic disparities in timeliness and comprehensiveness of dementia diagnosis in California. JAMA Neurol. 2021;78(6):657‐665.
Essien UR, Dusetzina SB, Gellad WF. A policy prescription for reducing health disparities‐achieving Pharmacoequity. JAMA. 2021;326(18):1793‐1794.